Levi & Korsinsky, LLP Investigates Possible Breach of Fiduciary Duty by the Board of Chattem, Inc.

Levi & Korsinsky is investigating potential claims against the Board of Directors of Chattem, Inc. (“Chattem” or the “Company”) (NasdaqGS: CHTT) in connection with the proposed sale of the Company to Sanofi-Aventis SA ("Sanofi-Aventis"). Under the terms of the transaction, Chattem shareholders are to receive $93.50 for each share of Chattem common stock they own for a total transaction value of approximately $1.9 billion.

The investigation concerns whether the Chattem Board of Directors breached their fiduciary duties to Chattem stockholders by failing to adequately shop the Company before entering into this transaction and whether Sanofi-Aventis is underpaying for Chattem shares, thus unlawfully harming Chattem stockholders.

If you are a current holder of Chattem and would like additional information, please contact us at the number listed below or visit http://www.zlk.com/chtt1.html.

Levi & Korsinsky has expertise in prosecuting investor securities litigation and extensive experience in actions involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation.

Chattem, Inc. (MM) (NASDAQ:CHTT)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024